Source: Health Canada shortage reports · Updated Oct 9, 2026
A shortage of Methylprednisolone is anticipated but not yet confirmed. 1 product(s) have anticipated-shortage reports on file with Health Canada.
A corticosteroid used to reduce inflammation and calm an overactive immune system.
Products affected
0 / 5
Reports on file
23
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Anticipated
DEPO-MEDROL
40MG · SUSPENSION · PFIZER CANADA ULC
DIN 00030759 · Disruption of the manufacture of the drug.
Resolved
DEPO-MEDROL
40MG · SUSPENSION · PFIZER CANADA ULC
DIN 00030759 · ended Jul 10, 2026 · Disruption of the manufacture of the drug.
Resolved
DEPO-MEDROL
80MG · SUSPENSION · PFIZER CANADA ULC
DIN 01934341 · ended Apr 9, 2026 · Disruption of the manufacture of the drug.
Resolved
DEPO-MEDROL
80MG · SUSPENSION · PFIZER CANADA ULC
DIN 00030767 · ended Mar 10, 2026 · Disruption of the manufacture of the drug.
Resolved
DEPO-MEDROL
80MG · SUSPENSION · PFIZER CANADA ULC
DIN 00030767 · ended Jan 5, 2026 · Disruption of the manufacture of the drug.
Resolved
DEPO-MEDROL
40MG · SUSPENSION · PFIZER CANADA ULC
DIN 00030759 · ended Dec 10, 2025 · Disruption of the manufacture of the drug.
Resolved
DEPO-MEDROL
40MG · SUSPENSION · PFIZER CANADA ULC
DIN 01934333 · ended Dec 2, 2025 · Disruption of the manufacture of the drug.
Resolved
DEPO-MEDROL (WITH PRESERVATIVE) 20 MG/ML
20MG · SUSPENSION · PFIZER CANADA ULC
DIN 01934325 · ended Oct 21, 2025 · Disruption of the manufacture of the drug.
Resolved
DEPO-MEDROL (WITH PRESERVATIVE) 40 MG/ML
40MG · SUSPENSION · PFIZER CANADA ULC
DIN 01934333 · ended Sep 25, 2025 · Disruption of the manufacture of the drug.
Resolved
DEPO-MEDROL 80 MG/ML
80MG · SUSPENSION · PFIZER CANADA ULC
DIN 00030767 · ended Jun 11, 2025 · Disruption of the manufacture of the drug.
Resolved
DEPO-MEDROL (WITH PRESERVATIVE) 80 MG/ML
80MG · SUSPENSION · PFIZER CANADA ULC
DIN 01934341 · ended May 1, 2025 · Disruption of the manufacture of the drug.
Resolved
DEPO-MEDROL 80 MG/ML
80MG · SUSPENSION · PFIZER CANADA ULC
DIN 00030767 · ended Mar 26, 2025 · Disruption of the manufacture of the drug.
Showing 12 of 23 reports. All reports are on file with Health Canada.
What's happening
A manufacturer has told Health Canada it expects supply of Methylprednisolone to fall short of demand. Anticipated shortages sometimes resolve without patients noticing; this page updates as soon as the status changes.
Methylprednisolone is classified under “CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN” (ATC H02AB).
Recent changes
Oct 9, 2026
Shortage resolved
Sep 16, 2026
Estimated end date pushed back : Sep 17, 2026 → Oct 30, 2026
Sep 9, 2026
New report filed
Jul 10, 2026
Status changed
Common questions
What is Methylprednisolone used for?
A corticosteroid used to reduce inflammation and calm an overactive immune system.
When will Methylprednisolone be back in stock in Canada?
Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.
Why is Methylprednisolone in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.